XDemics

Drug Discovery · Cell & Gene Therapy

Overview

XDemics is fundamentally improving the way cells are grown, with 10–100X higher cell yields than conventional approaches, in cultureware and in bioreactors.

Funding and backers

Total raised
$12.9M
3 rounds on record
Latest round
$7.4M
Venture round · Oct 2025 · 12 mo ago
Team
51-200
employees, estimated range
The money's age
Due for its next round
12 months since the last round · not hiring
Momentum
0/100
no fresh signals
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Oct 21, 2025 Raised a round Venture round $7.4M · SEC Form D Nov 21, 2024 Raised a round Venture round $5.5M · SEC Form D May 30, 2024 Took on debt financing $1.9M · SEC Form D
Funding rounds
RoundDateAmountInvestorsSource
Venture round Oct 2025 $7.4M — SEC Form D
Venture round Nov 2024 $5.5M — SEC Form D
Debt Financing May 2024 $1.9M — SEC Form D
Registers and programsofficial lists and records that name the company
Legal entity XDemics Corp SEC Form D
Founders and leadersfrom filings, registers and the company's site
Christopher ThanosExecutive Officer, DirectorSEC Form D
Investors in similar startupsfunds that back the companies most like this one
Y Combinator
backs LEAH Labs
Lightstone Ventures
backs MediSix Therapeutics
Northern Light Venture Capital
backs Applied Cells
Similar startupsby what they do, their industry and backers
GeneVentiv TherapeuticsVenture round $1.4M · 4 yr ago · Founded 2020 · 11-50 employees
GeneVentiv Therapeutics — advancing gene therapy approaches.
LEAH LabsFounded 2018 · 11-50 employees
Designer cell therapies for pets first and their people next.
MediSix Therapeutics
MediSix Therapeutics develops innovative T-cell therapies using its proprietary PEBL technology platform. An IASO Biotechnology subsidiary.
PluristyxVenture round $9.8M · 4 mo ago · 11-50 employees
Pluristyx provides cell therapy solutions to support the manufacturing and development of custom stem cell products. Provider of induced…
Immorta BioVenture round $613k · 2 yr ago · Founded 2023 · 11-50 employees
Immorta Bio is a longevity biotech company developing stem-cell and senescent-cell therapeutics to reverse biological aging and unlock…
BlueWhale BioVenture round $5M · 12 mo ago · Founded 2022
Cell Therapy Success Starts Here Synecta™ Activation and Expansion Solutions.

Visa sponsorship

#5,755 of 8,998 sponsors
United StatesUS 1
1
H-1B filings in 12 months
$88k
Median offered salary
0
Open roles in United States
Who they sponsor
Biological technicians
1
The salary offered for each occupationVisa pass · 90 credits
In the register as XDemics Corporation, Novato, CA
Other sponsors in the same field
Cambium Oncology 1 filingsAldevron 11 filingsVyriad 5 filingsIntegrated DNA Technologies 3 filings
Alert me
US Department of Labor · latest filing Nov 14, 2025 · Visa details by country

Financials

Total raised
$14.8M
Latest round
Venture - Series Unknown
Funding rounds
3
Funding rounds
Round Announced Amount
Venture - Series Unknown 2025 $7.4M Details
Venture - Series Unknown 2024 $5.5M Details
Debt Financing 2024 $1.9M Details

People

Christopher Thanos
Executive Officer, Director
SEC Form D
Colin Cook
Director
SEC Form D
Nicole Bergman
Director
SEC Form D
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
San Rafael United States
HQ
50-200 est. staff